2019-nCoV CDC-qualified Probe and Primer Kits for SARS-CoV-2 by LGC, Biosearch Technologies

Manufacturer LGC, Biosearch Technologies  |   Model: KIT-NCOV-PP1-1000  |  Available Worldwide
3.8
/
5.0
  |  2 reviews
The kits include FAM-BHQ probes and primers mixed into a single assay per signature as required by protocols provided by the CDC. Oligos are delivered dried and shipped at ambient temperature.


2019-nCoV CDC-qualified Probe and Primer Kits for SARS-CoV-2 by LGC, Biosearch Technologies product image
2019-nCoV CDC-qualified Probe and Primer Kits for SARS-CoV-2
Request Pricing

Receive your quote directly from the manufacturer.




Average Rating: 3.8
2 Scientists have reviewed this product

4 out of 5
Ease of use
4 out of 5
After sales service
4 out of 5
Value for money


  • Status:

    Reviewer
  • Member since: 2020

  • Organization: Pfizer



  • Ease of use
    5 out of 5
    After sales service
    4 out of 5
    Value for money
    4 out of 5
Share this Review on LinkedinShare this Review on TwitterShare this Review on Facebook
Great product, easy to use.
Rating: 4.3

  • Application Area: Development of in house testing (not patient samples)

"The kit was super straightforward and easy to use. All materials fit into the CDC published method for COVID-19 testing. No issues with getting reproducible results."

Review date: 23 Jul 2020 | 2019-nCoV CDC-qualified Probe and Primer Kits for SARS-CoV-2
  • Status:

    Reviewer

  • Member since: 2020

  • Organization: Pace Laboratories Kenya



  • Ease of use
    3 out of 5
    After sales service
    3 out of 5
    Value for money
    4 out of 5
Share this ReviewShare this Review on TwitterShare this Review
Novel invention with priceless ingenuity and ease of use for the end user.
Rating: 3.3

  • Application Area:Analyze antibodies in blood

"Easy to use for even a scientific layperson via a well detailed user manual accompanying the product. Gives high specificity and very reproducible results. Highly recommend to diagnostic laboratories and even researchers in institutions with high test turnovers not executable via PCR."

Review date: 30 Jun 2020 | 2019-nCoV CDC-qualified Probe and Primer Kits for SARS-CoV-2

With a proven track record supporting public health crises and the expertise to rapidly scale up high-quality oligonucleotide production to meet growing demand for testing reagents, LGC, Biosearch Technologies is prepared to support testing to help slow the spread of COVID-19.

Key features

  • Each lot of the probe and primer set is released for distribution by CDC testing results
  • Product in stock ships same or next business day
  • From the trusted inventor and original source of Black Hole Quencher™ (BHQ™) technology referenced in US CDC protocols
  • Proven track record supporting public health crises with the expertise to rapidly scale up

Contents

  • The 2019-nCoV CDC Probe and Primer Kit contains signatures for SARS-CoV-2 where each assay contains 1 probe and 2 primers mixed into the same tube in dried format. Each assay contains 2.5 nmol of probe and 10 nmol of each primer, yielding a total amount of 22.5 nmol per tube.